United Therapeutics (UTHR) Tops Q4 EPS by 17c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
United Therapeutics Corp. (UTHR) PT Raised to $196 at Credit Suisse
February 22, 2021 4:32 AM ESTCredit Suisse analyst Martin Auster raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $196.00 (from $169.00) while maintaining a Outperform rating.... More
